Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Crooks, E. T.
  • Grimley, S. L.
  • Cully, M.
  • Osawa, K.
  • Dekkers, G.
  • Saunders, K.
  • Ramisch, S.
  • Menis, S.
  • Schief, William
  • Doria-Rose, N.
  • Haynes, B.
  • Murrell, B.
  • Cale, E. M.
  • Pegu, A.
  • Mascola, J. R.
  • Vidarsson, G.
  • Binley, J. M.

publication date

  • May 2018

journal

  • PLoS Pathogens  Journal

subject areas

  • Antibodies, Neutralizing
  • Epitopes
  • Glycosylation
  • HIV Antibodies
  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp41
  • HIV Infections
  • HIV-1
  • Humans
  • Leukocytes, Mononuclear
  • Polysaccharides
  • Protein Conformation
scroll to property group menus

Identity

PubMed Central ID

  • PMC5951585

International Standard Serial Number (ISSN)

  • 1553-7366

Digital Object Identifier (DOI)

  • 10.1371/journal.ppat.1007024

PubMed ID

  • 29718999
scroll to property group menus

Additional Document Info

volume

  • 14

issue

  • 5

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support